Profile
Katsumi Aoyagi is Director at Fujirebio, Inc. and Executive Officer & Head-R&D at H.U.
Group Holdings, Inc. starting in 2026.
Formerly, Mr. Aoyagi was President & Representative Director at Advanced Life Science Institute KK.
Katsumi Aoyagi active positions
| Companies | Position | Start |
|---|---|---|
| H.U. GROUP HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 16/06/2026 |
Fujirebio, Inc.
Fujirebio, Inc. Medical SpecialtiesHealth Technology Manufactures, wholesales, and imports analytical drugs and equipments | Director/Board Member | - |
Former positions of Katsumi Aoyagi
| Companies | Position | End |
|---|---|---|
Advanced Life Science Institute KK
Advanced Life Science Institute KK Pharmaceuticals: MajorHealth Technology Manufactures and wholesales testing drugs of hepatitis viruses and lung cancers | President | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Fujirebio, Inc.
Fujirebio, Inc. Medical SpecialtiesHealth Technology Manufactures, wholesales, and imports analytical drugs and equipments | Health Technology |
H.U. Group Holdings, Inc.
H.U. Group Holdings, Inc. Medical/Nursing ServicesHealth Services Operates as a holding company with interests in manufacturing of diagnostic drugs and equipments | Health Services |
Advanced Life Science Institute KK
Advanced Life Science Institute KK Pharmaceuticals: MajorHealth Technology Manufactures and wholesales testing drugs of hepatitis viruses and lung cancers | Health Technology |
- Stock Market
- Insiders
- Katsumi Aoyagi
















